BML Investment Partners discloses 9.5% Instil Bio (TIL) stake in amended 13G

Rhea-AI Filing Summary

Instil Bio, Inc. (TIL) received an amended Schedule 13G filing showing that BML Investment Partners, L.P., a Delaware entity, beneficially owns 645,600 shares of Instil Bio common stock. This represents 9.5% of the outstanding common shares as of the event date.

BML reports shared voting and dispositive power over all 645,600 shares and no sole voting or dispositive power. The filing is certified as being made for investment purposes, not to change or influence control of Instil Bio.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Instil Bio, Inc.

(Name of Issuer)

Common Stock, $0.000001 par value per share

(Title of Class of Securities)

45783C101

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 45783C101

1

Names of Reporting Persons

BML Investment Partners, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 645,600.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 645,600.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

645,600.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.5 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Instil Bio, Inc.
(b)	Address of issuer's principal executive offices: 3963 Maple Avenue, Suite 350, Dallas, Texas, 75219
Item 2.
(a)	Name of person filing: BML Investmetn Partners, L.P.
(b)	Address or principal business office or, if none, residence: 65 E Cedar - Suite 2
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, $0.000001 par value per share
(e)	CUSIP No.: 45783C101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 645600
(b)	Percent of class: 9.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 645600
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 645600
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BML Investment Partners, L.P.

Signature:	Braden M Leonard
Name/Title:	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:	02/09/2026

FAQ

What percentage of Instil Bio (TIL) does BML Investment Partners own?

BML Investment Partners, L.P. reports beneficial ownership of 9.5% of Instil Bio’s common stock. This corresponds to 645,600 shares, according to the amended Schedule 13G filed for the event dated 12/31/2025.

How many Instil Bio (TIL) shares does BML Investment Partners control?

BML Investment Partners, L.P. reports beneficial ownership of 645,600 Instil Bio common shares. It has shared voting and shared dispositive power over all 645,600 shares and reports no sole voting or dispositive authority.

What type of filing did BML Investment Partners submit for Instil Bio (TIL)?

BML Investment Partners, L.P. submitted an Amendment No. 2 to Schedule 13G for Instil Bio, Inc. This filing reports passive beneficial ownership of common stock instead of an intent to change or influence control of the company.

Who signed the Schedule 13G/A for Instil Bio (TIL) on behalf of BML Investment Partners?

The filing is signed by Braden M. Leonard for BML Capital Management, LLC, which is the general partner of BML Investment Partners, L.P. He signs as the Managing Member, certifying the accuracy of the ownership information.

What class of Instil Bio (TIL) securities is covered in this Schedule 13G/A?

The Schedule 13G/A covers Instil Bio, Inc. common stock with a par value of $0.000001 per share. The securities are identified by CUSIP 45783C101, as disclosed in the ownership reporting sections of the document.

Is BML Investment Partners seeking control of Instil Bio (TIL)?

The filer certifies the securities were not acquired and are not held to change or influence control of Instil Bio. The shares are held for investment purposes, consistent with the passive ownership standard of a Schedule 13G filing.